Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy

Documenti analoghi

• Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
  di: Steuber, Thomas, et al.
  Pubblicazione: (2006)
• Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy
  di: O'Brien, Matthew Frank, et al.
  Pubblicazione: (2009)
• Comparison of Observed Biochemical Recurrence Free Survival in Patients with Low PSA Values Undergoing Radical Prostatectomy to the Predictions of a Preoperative Nomogram
  di: Berglund, Ryan K, et al.
  Pubblicazione: (2009)
• Is it necessary to remove the Seminal Vesicles completely at the time of Radical Prostatectomy? Decision curve analysis of the European Society of Urologic Oncology criteria
  di: Secin, Fernando P., et al.
  Pubblicazione: (2008)
• Timing of PSA nadir after radical prostatectomy and risk of biochemical recurrence
  di: Skove, Stephanie L., et al.
  Pubblicazione: (2017)